Charles River Laboratories partners with Medigen on sequencing programs
Charles River Laboratories (CRL) and Medigen Vaccine Biologics Corp collaborate to advance new vaccine development programs through next generation sequencing.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Charles River Laboratories (CRL) and Medigen Vaccine Biologics Corp collaborate to advance new vaccine development programs through next generation sequencing.
Charles River Laboratories and Medigen Vaccine Biologics Corp collaborate to advance new vaccine development programs through next-generation sequencing.